- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03034746
Impact of Physical Activity on Successful Aging
Impact of Physical Activity on Successful Aging: Multidisciplinary Analysis of Mechanisms and Outcomes
Emerging literature suggests that vascular factors might be involved in the pathogenesis of Alzheimer's disease (AD). Other recent studies demonstrate the positive effects of physical activity on cognitive and behavioral disturbances of patients with AD. Therefore, it has been postulated that exercise enchantment in cerebral circulation is the physiological mechanism that link physical exercise and reduction of AD symptoms. Consequently, a program of physical activity could be considered one approach to counteract dementia by improving cerebrovascular health.
However at this moment, it is not clear if the progressive brain vascular dysfunction and hypoperfusion, associated with the β-amyloid deposition, might be reversed or stabilized by an exercise intervention.
The aim of this study is to assess, in patients with AD, the influence of physical exercise, compared to cognitive stimulation, on:
- Cognitive function;
- Independence in daily living and behavioral symptoms;
- Vascular function Finally, to investigate the physiological processes on the basis of the motor parameters' changes, the performances of the patients will be compared with the performances of healthy young and old subjects.
MAIN OBJECTIVE: Investigate, in patients with Mild Cognitive Impairment (MCI) and AD, the effects of a physical activity program, or cognitive stimulation on global cognitive function.
SECONDARY OBJECTIVES: Investigate the effects of the two treatments on:
- cognitive and motor performances,
- independence in activities of daily living,
- behavioral symptoms,
- peripheral vascular function.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
STUDY DESIGN:
Randomised controlled, blinded clinical trial.
SUBJECTS:
The study will include 120 patients with definite diagnosis of MCI or AD and 30 young healthy subjects and 30 old healthy subjects referred to the Research Unit associated with the Department.
Patients will be regarded as suitable to participate if they fulfilled the following criteria:
- Mini Mental State Examination (MMSE) ≥ 8;
- Performance Oriented Mobility Assessment ≥ 19 (POMA).
Exclusion criteria will be:
- presence of other concurrent neurological diseases;
- presence of other orthopaedic diseases involving the lower limbs and/or interfering with standing position and/or walking;
- presence of severe auditory and visual deficits not corrected;
- abuse of alcohol or drugs;
- psychiatric disorders,
- severe behavioral disorders;
- hearth and respiratory disease that interfere with the motor activity. The protocol was be approved by the local ethics committee with number 2389. All participants will perform a physiatric examination by a medical doctor of the Department of Neurological and Movement Sciences. Written inform consent will be obtained from all participants before inclusion in the study.
Participants who will meet the inclusion criteria will conduct a clinical and instrumental evaluation at enrollment (T0) and after 6 months ± 15 days after the first visit (T1). The assessment procedures will also be repeated after 3 months (T2) from T1.
ASSESSMENT PROCEDURES
Primary endpoints:
- score obtained in the Mini Mental State Examination.
Secondary endpoints:
- score obtained in a cognitive battery.
For MCI patients will be used:
- Trial Making Test (Reitan,1958),
- Rivermead Behavioral Memory Test (Wilson, 1989),
- Tower of London (Shallice, 1982),
- Dual Task (Della Sala et al., 1997),
- Frontal Assessment Battery (Iavarone A et al., 2004).
For AD patients will be used:
- Attention Matrix (Spinnler et al., 1987),
- Alzheimer's Disease Assessment Scale (Rosen WG et al., 1984),
Frontal Assessment Battery (Iavarone A et al., 2004).
- score obtained in a motor skills assessment composed by:
- 6-Minute Walking Test (Ries JD et al., 2009),
- gait analysis by GAITRite® System (Bilney B et al., 2003),
stabilometric assessments with Stability Line (Nashner LM and Peters JF, 1990),
- score obtained in the test Instrumental Activity in Daily Living (Lawton MP and Brody EM, 1969),
- score obtained in the test Neuropsychiatric Inventory (Cummings JL et al., 1994),
- peripheral vascular function measured by doppler.
To evaluate the effectiveness of motor treatment, compared to a cognitive treatment on motor skills, cognitive skills, behavioral and autonomy in patients with cognitive decline, all patients will be evaluated by motor, cognitive, behavioral and autonomy scales, at baseline, after 6 months (T1), and after others 3 months (T2). A subgroup of 50% of patients will undergo instrumental procedures to investigate the effects of treatments on cerebral blood flow (arterial spin labeling).
TREATMENT PROCEDURES
The participants will be recruited and randomly assigned, according to the degree of cognitive decline, to one of the 3 groups (7-8 subjects):
- Physical Activity group (PA group): It will perform a program consist of 15 min of warm-up, 60 min of aerobic and resistance training, and 15 min of cool-down.
- Cognitive treatment group (CT group): The cognitive stimulation group will received a rehabilitation program with multimodal repetitive stimulation in order to exercise and reinforce the cognitive skills of the participant to slow/prevent the decline. In particular the treatment will be focused on reorient the patient about his/her-self, his/her history and his/her environment, to improve the memory skill by teaching compensatory and restitutive strategies, to help the patient to the discussion about everyday life and in particular to the everyday problems The PA and CT groups will be homogeneous for clinical and demographic data, and participants will undergo 72 treatment group sessions, 60-minute/session, and 3 days/week for 6 consecutively months.
Both types of treatment will be balanced with different degrees of difficulty depending on the state of disease severity .
o The control groups (CG) will not receive any such treatment during the study and they will be evaluated by the same clinical and instrumental assessments.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- age ≥ 65 years;
- Mini Mental State Examination (MMSE) ≥ 8;
- Performance Oriented Mobility Assessment ≥ 19 (POMA).
Exclusion Criteria:
- presence of other concurrent neurological diseases;
- presence of other orthopaedic diseases involving the lower limbs and/or interfering with standing position and/or walking;
- presence of severe auditory and visual deficits not corrected;
- abuse of alcohol or drugs;
- psychiatric disorders,
- severe behavioral disorders;
- hearth and respiratory disease that interfere with the motor activity.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Alzheimer's Disease (G1)
(G1) physical activity (PA)
|
It will perform a program consist of 15 min of warm-up, 60 min of aerobic and resistance training, and 15 min of cool-down.
|
Eksperimentel: Alzheimer's Disease (G2)
(G2) cognitive treatment (CT)
|
The cognitive stimulation group will received a rehabilitation program with multimodal repetitive stimulation in order to exercise and reinforce the cognitive skills of the participant to slow/prevent the decline.
In particular the treatment will be focused on reorient the patient about his/her-self, his/her history and his/her environment, to improve the memory skill by teaching compensatory and restitutive strategies, to help the patient to the discussion about everyday life and in particular to the everyday problems
|
Ingen indgriben: Healthy Old Subjects (G1)
Control group old
|
|
Ingen indgriben: Healthy young Subjects (G2)
Control group young
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Mini Mental State Examination
Tidsramme: 0-6-9 months (change will be assessed)
|
0-6-9 months (change will be assessed)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Trail Making Test
Tidsramme: 0-6-9 months (change will be assessed)
|
For MCI patients (Reitan,1958)
|
0-6-9 months (change will be assessed)
|
Rivermead Behavioral Memory Test
Tidsramme: 0-6-9 months (change will be assessed)
|
For MCI patients (Wilson, 1989)
|
0-6-9 months (change will be assessed)
|
Tower of London
Tidsramme: 0-6-9 months (change will be assessed)
|
For MCI patients (Shallice, 1982)
|
0-6-9 months (change will be assessed)
|
Dual Task
Tidsramme: 0-6-9 months (change will be assessed)
|
For MCI patients (Della Sala et al., 1997)
|
0-6-9 months (change will be assessed)
|
Frontal Assessment Battery
Tidsramme: 0-6-9 months (change will be assessed)
|
(Iavarone A et al., 2004)
|
0-6-9 months (change will be assessed)
|
Attention Matrix
Tidsramme: 0-6-9 months (change will be assessed)
|
For AD patients (Spinnler et al., 1987)
|
0-6-9 months (change will be assessed)
|
Alzheimer's Disease Assessment Scale
Tidsramme: 0-6-9 months (change will be assessed)
|
For AD patients (Rosen WG et al., 1984)
|
0-6-9 months (change will be assessed)
|
6-Minute Walking Test
Tidsramme: 0-6-9 months (change will be assessed)
|
(Ries JD et al., 2009)
|
0-6-9 months (change will be assessed)
|
gait analysis by GAITRite® System
Tidsramme: 0-6-9 months (change will be assessed)
|
(Bilney B et al., 2003)
|
0-6-9 months (change will be assessed)
|
stabilometric assessments with Stability Line
Tidsramme: 0-6-9 months (change will be assessed)
|
(Nashner LM and Peters JF, 1990),
|
0-6-9 months (change will be assessed)
|
Instrumental Activity in Daily Living Scale (IADL)
Tidsramme: 0-6-9 months (change will be assessed)
|
0-6-9 months (change will be assessed)
|
|
Neuropsychiatric Inventory Scale (NPI)
Tidsramme: 0-6-9 months (change will be assessed)
|
0-6-9 months (change will be assessed)
|
|
cerebral circulation
Tidsramme: 0-6-9 months (change will be assessed)
|
measured MRI arterial spin labeling
|
0-6-9 months (change will be assessed)
|
peripheral vascular function
Tidsramme: 0-6-9 months (change will be assessed)
|
measured by vascular doppler
|
0-6-9 months (change will be assessed)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studiestol: Nicola Smania, Department of Neurological and Movement Sciences
- Ledende efterforsker: Federico Schena, Department of Neurological and Movement Sciences
Publikationer og nyttige links
Generelle publikationer
- Venturelli M, Lanza M, Muti E, Schena F. Positive effects of physical training in activity of daily living-dependent older adults. Exp Aging Res. 2010 Apr;36(2):190-205. doi: 10.1080/03610731003613771.
- Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. doi: 10.1177/1533317511418956. Epub 2011 Aug 17.
- Venturelli M, Magalini A, Scarsini R, Schena F. From Alzheimer's disease retrogenesis: a new care strategy for patients with advanced dementia. Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):483-9. doi: 10.1177/1533317512459794. Epub 2012 Sep 13.
- Venturelli M, Scarsini R, Muti E, Salvagno GL, Schena F. Sundowning syndrome and hypothalamic-pituitary-adrenal axis dysregulation in individuals with Alzheimer's disease: is there an association? J Am Geriatr Soc. 2013 Nov;61(11):2055-6. doi: 10.1111/jgs.12491. No abstract available.
- Venturelli M, Ce E, Limonta E, Muti E, Scarsini R, Brasioli A, Schena F, Esposito F. Possible Predictors of Involuntary Weight Loss in Patients with Alzheimer's Disease. PLoS One. 2016 Jun 27;11(6):e0157384. doi: 10.1371/journal.pone.0157384. eCollection 2016.
- Venturelli M, Sollima A, Ce E, Limonta E, Bisconti AV, Brasioli A, Muti E, Esposito F. Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease. J Alzheimers Dis. 2016 Jul 14;53(4):1631-40. doi: 10.3233/JAD-160392.
- Crispoltoni L, Stabile AM, Pistilli A, Venturelli M, Cerulli G, Fonte C, Smania N, Schena F, Rende M. Changes in Plasma beta-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression. J Alzheimers Dis. 2017;55(3):1005-1017. doi: 10.3233/JAD-160625.
- Pedrinolla A, Venturelli M, Tamburin S, Fonte C, Stabile AM, Galazzo IB, Ghinassi B, Venneri MA, Pizzini FB, Muti E, Smania N, Di Baldassarre A, Naro F, Rende M, Schena F. Non-Abeta-Dependent Factors Associated with Global Cognitive and Physical Function in Alzheimer's Disease: A Pilot Multivariate Analysis. J Clin Med. 2019 Feb 9;8(2):224. doi: 10.3390/jcm8020224.
- Pedrinolla A, Venturelli M, Fonte C, Munari D, Benetti MV, Rudi D, Tamburin S, Muti E, Zanolla L, Smania N, Schena F. Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study. J Alzheimers Dis. 2018;61(4):1599-1609. doi: 10.3233/JAD-170625.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PRIN_2010
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Fysisk aktivitet
-
University of ValenciaAktiv, ikke rekrutterendeAutismespektrumforstyrrelse | Attention Deficit Hyper ActivitySpanien
-
NYU Langone HealthAfsluttetAttention Deficit Hyper ActivityForenede Stater
-
Texas Woman's UniversityAfsluttetIntellektuel handicap | Autismespektrumforstyrrelse | Motoriske lidelser | Motorforsinkelse | Sanseforstyrrelser | Attention Deficit Hyper Activity
-
Cingulate TherapeuticsPremier Research Group plcAktiv, ikke rekrutterendeADHD | Attention Deficit Hyperactivity Disorder | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Cingulate TherapeuticsRekrutteringADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder med hyperaktivitet | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking...RekrutteringAldersinterval ≥16 år, køn ubegrænset | Histopatologi bekræftet diffust stort B-celle lymfom eller højgradigt B-celle lymfom | Modtaget tidligere førstelinjekemoterapi for DLBCL eller HGBL, kunne ikke nå CR i fire cyklusser eller tilbagefald | Mindst én positiv læsion ifølge 2014 Lugano-kriterierne... og andre forholdKina
Kliniske forsøg med Physical activity (PA)
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetFysisk aktivitetForenede Stater
-
The Miriam HospitalUkendtSlag | Stillesiddende livsstil | Iskæmisk angreb, forbigående | Dyrke motionForenede Stater
-
Centre Hospitalier Universitaire de Saint EtienneNational Cancer Institute, FranceAfsluttetKræft prostataFrankrig
-
Cairo UniversityTilmelding efter invitation
-
IVI BilbaoInstituto Valenciano de Infertilidad, IVI VALENCIAAfsluttet
-
Istanbul Kültür UniversityMarmara University; Istanbul University - Cerrahpasa (IUC)AfsluttetFysisk aktivitet | Parkinsons sygdom | Balance | Falder | KinesiofobiKalkun
-
Istanbul Kültür UniversityTrukket tilbageFysisk aktivitetsniveau | Bevidsthed om fysisk aktivitet
-
Memorial Sloan Kettering Cancer CenterAktiv, ikke rekrutterendeKarcinom | KræftForenede Stater
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Roche Diagnostics GmbHIkke rekrutterer endnuKardiomyopatier | Genetisk disposition | Kardiomyopati, Primær